Baird Financial Group, Inc. Nuvasive Inc Transaction History

Baird Financial Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$46.84 - $59.75 $1,779 - $2,270	38 Added 0.55%	6,915 $340,000
Q1 2022 May 13, 2022	SELL	$48.09 - $57.79 $11,156 - $13,407	-232 Reduced 3.26%	6,877 $390,000
Q3 2021 Nov 12, 2021	BUY	$56.91 - $67.81 $404,573 - $482,061	7,109 New	7,109 $425,000
Q1 2018 May 14, 2018	SELL	$46.03 - $61.28 $161,105 - $214,480	-3,500 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$50.58 - $60.79 $177,030 - $212,765	3,500 New	3,500 $205,000
Q3 2017 Nov 14, 2017	SELL	$53.54 - $68.0 $188,353 - $239,224	-3,518 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	3,518	3,518 $271,000

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Baird Financial Group, Inc. with notifications on news.